Skin Boosters Explained: Types, Ingredients, Results & Safety

---

1. What Is a Skin Booster? The Secret to Glass Skin

"My skin is so dry no matter what I do." "Moisturizers just don't seem to last." Sound familiar?

A Skin Booster is an injectable treatment that delivers deep hydration to your skin. Unlike topical moisturizers that only sit on the surface, skin boosters inject hyaluronic acid (HA) and nutrients directly into the dermal layer, hydrating your skin from within.

Skin Booster vs Regular Moisturizer: What's the Difference?

Feature	Skin Booster (Injectable)	Moisturizer (Topical)
Depth	Injection plane varies by product and technique	Applied to the skin surface
Duration	varies by product, formulation, area, and plan	Varies by product and skin condition
Hydration	Product- and technique-specific injection plane	Surface only
Effect	Change must be assessed for the individual product and goal	Topical moisturization and barrier support

While moisturizers only cover the surface, skin boosters improve the skin structure itself!

---

2. How Skin Boosters Work

Here's a step-by-step breakdown of how skin boosters improve your skin.

Step 1: Hyaluronic Acid (HA) Injection

Hyaluronic acid is a naturally occurring substance in our skin. Remarkably, it can absorb up to 1,000 times its weight in water!

The problem is that our skin's HA decreases with age — dropping about 1% per year from age 28, leading to dryness and loss of elasticity.

Step 2: Collagen Stimulation

Skin booster ingredients don't just provide hydration. They stimulate fibroblasts to produce new collagen and elastin.

This process occurs over 2-3 months, gradually making your skin firmer and healthier!

Step 3: Skin Barrier Restoration

Dry, damaged skin has a weakened skin barrier. Skin boosters improve the physiological environment of the dermis, restoring the skin barrier.

---

3. Types of Skin Boosters: Which One Is Right for You?

1. HA-Based Skin Boosters

Products: Restylane Skinboosters Vital, Juvederm Volite

• Ingredient: Crosslinked hyaluronic acid
• Feature: Verify formulation, intended use, and product-specific human evidence
• Duration: varies by product, formulation, area, and plan
• Consultation question: What explains the dryness, what alternatives exist, and what evidence concerns the actual product?

2. PN-Based Skin Boosters

Products: Rejuran, Rejuran HB Plus

• Ingredient: Ingredients differ by PN product; Rejuran HB plus has a separate IFU from the original product
• Feature: Separate the intended goal, evidence, and injection reactions for the actual product
• Duration: Do not apply a fixed duration or series; review direct product evidence and the first response
• Consultation question: Why this product, what anesthesia method, and what contraindications and pain response plan?

What makes Rejuran HB Plus special: It is a separate product containing lidocaine and HA; check its own IFU, ingredients, contraindications, intended use, and evidence instead of assigning a fixed pain reduction or glow outcome.

3. Hybrid HA Skin Boosters

Product: Profhilo

• Ingredient: High + low molecular weight HA blend
• Feature: Scope described in the actual product document and human research
• Duration: Varies with the product study conditions and individual course
• Consultation question: Verify the actual product, area, goal, alternatives, and evidence

---

4. Juvelook: PDLLA + non-crosslinked HA category

Juvelook belongs to a PDLLA plus non-crosslinked HA category. Its concept differs from an HA-only hydration procedure. Consultation should address the intended texture or elasticity goal as well as limitations such as delayed nodules reported with injectable collagen stimulators. Composition and physical properties differ among polylactic-acid products, so results from another PLA product cannot automatically be transferred to Juvelook. (Reference: PMC12787764)

5. Re2O: human acellular dermal-matrix-derived ECM category

Re2O is categorized as an extracellular-matrix material derived from human acellular dermal matrix. It starts from a different material concept than HA, PN, or a biodegradable polymer intended to provoke a collagen response. Product classification, intended use, and clinical evidence therefore need separate review rather than a single ranking. A randomized study has been reported, but its sample size, follow-up period, and disclosed product-development advisory relationship limit conclusions about long-term outcomes or superiority over other categories. (Reference: PMC12985180)

6. GOURI: liquid PCL category

GOURI should be identified as a liquid PCL category, not PN plus HA. Published material includes a case observing tissue change after liquid PCL use, but a single case cannot establish a general effect or incidence. Consultation should review the ingredient, injection plan, previous procedures, known adverse reactions, and the uncertainty around gradual change. (Reference: PMID 39703099)

7. KLOSOME: verify the product category and product-specific evidence first

For a newer branded option such as KLOSOME, the name alone does not establish its ingredient, regulatory scope, method of use, or clinical evidence. Exosome literature discusses possible applications but also calls for more human clinical research; it cannot be expanded into proof for KLOSOME itself. Do not assert unverified regenerative, brightening, or anti-aging outcomes. (Reference: PMC11608875)

What to compare across ingredient categories

Category	Example	First question at consultation
HA	Restylane Skinboosters, Juvederm Volite	Crosslinking, hydration or texture goal, individual variation in duration and reactions
PN	Rejuran	Exact product and ingredient, injection reactions, evidence for a repeat plan
Hybrid HA	Profhilo	How its formulation and intended use differ from another HA injection
PDLLA + HA	Juvelook	Collagen-stimulation goal, injection plan, and delayed reactions including nodules
Human acellular dermal-matrix-derived ECM	Re2O	Product classification, limits of human evidence, and gaps in long-term data
Liquid PCL	GOURI	Expected gradual course, previous procedures, and the limits of case-level evidence
Newer branded option	KLOSOME	Ingredient, regulatory scope, method, and product-specific clinical data

This is a consultation framework, not a ranking. Narrow the category only after reviewing skin thickness, inflammation, primary concern, previous procedures, recovery schedule, and acceptable risk.

4. Benefits of Skin Boosters

1. Increased Skin Hydration

The fastest noticeable effect! Within 48-72 hours, you'll feel your skin becoming more hydrated.

• Dry skin becomes soft and supple
• Makeup applies more smoothly
• Skin texture becomes refined

2. Improved Skin Elasticity

Over 2-3 months as new collagen is produced:

• Fine lines diminish
• Skin becomes firmer and bouncier

3. Even Skin Tone

• Dull skin becomes brighter
• Skin tone evens out
• Healthy radiance appears

4. Pore Reduction

• Pores become visibly smaller
• Skin texture refines

5. Skin Regeneration

Especially with PN-based boosters (Rejuran):

• Damaged tissue repair
• Improved elasticity and density
• Skin barrier strengthening

---

5. When Should Effects and Progress Be Assessed?

“Skin booster” does not identify one product or protocol, so there is no universal onset date, peak date, or duration for every ingredient. The sequence below is a follow-up framework for reading the actual product document and individual plan, not a promise of outcome.

1. Identify the exact product and ingredient category first

Record the exact product, ingredient category, amount, area, injection method, and every combined procedure—not only a commercial category name. HA, PN, PDLLA plus HA, human-acellular-dermal-matrix-derived ECM, and liquid PCL have different evidence and risks; a timeline or result from one category cannot be transferred to another.

2. Document a pretreatment baseline

Keep photographs with consistent light, distance, and angle, along with the primary concern, active inflammation or skin disease, recent procedures, medicines and supplements, and important dates. Without a baseline, natural change, the immediate injection appearance, temporary reactions, and later findings are difficult to separate.

3. Immediately after treatment, assess the initial reaction rather than the result

Early fullness or shine may reflect injected volume, mixed components, swelling, and lighting; it is not a long-term outcome. First confirm that the actual product, area, and amount match the consent record and that the expected reactions and contact route are understood.

4. At early follow-up, assess persistence, worsening, and asymmetry

Injection marks, redness, swelling, bruising, pain, itching, and palpable change vary in occurrence and duration. Do not wait for a fixed date when a reaction persists or enlarges beyond the written expectation or is accompanied by increasing pain, color change, warmth, discharge, or systemic symptoms; use the documented review route.

5. At later follow-up, reassess the same goal measures

Compare the original hydration, texture, or elasticity goal using standardized photographs and examination. Consider other procedures, daily factors, and photography conditions. Satisfaction alone cannot establish a product-only effect or duration.

6. Read study time points with the study conditions attached

Participant count, anatomical area, product, mixture, injection technique, treatment series, comparator, and follow-up must be compared with the proposed plan. A category review does not prove an individual product, and a single case cannot establish incidence or superiority.

7. Do not set a repeat or maintenance plan automatically

Decide only after reviewing the first response, unexpected findings, goal attainment, and any new contraindication. A fixed series or interval does not apply to everyone, and repeating treatment does not guarantee extension of the same result.

8. Follow-up record

Stage	Record	Decision rule
Before	Product, ingredient, area, amount, baseline photographs, medicines, schedule	Document the individual goal, alternatives, and evidence scope
Early follow-up	Onset, persistence, worsening, asymmetry, photographs	Assess difference from written expectation, not a fixed recovery date
Later follow-up	Standardized photographs, examination, original goal measures	Do not assume product-only effect or an automatic repeat need

6. Recovery and Safety Must Be Checked Against the Product Document

The category name alone cannot set recovery time or contraindications. Written instructions vary with the actual product, mixed components, area, injection method, combined procedure, and skin condition.

1. Check the label and IFU for the actual product

Verify product, model and amount, lot, ingredients, authorized or notified scope, contraindications, and adverse reactions. Compare the consultation record with the package. A category review or another product's instructions do not replace the actual product document.

2. Temporary reactions vary in occurrence and duration

Injection marks, redness, swelling, bruising, tenderness, itching, or palpable changes can occur, but one pattern or duration does not apply to everyone. Record onset, extent, persistence, and worsening.

3. Do not wait for a fixed date when a reaction is unexpected

Use the documented contact route or local emergency care for increasing pain, color change, enlarging swelling or firmness, warmth, discharge, visual change, neurologic symptoms, breathing difficulty, or systemic symptoms. An online article cannot diagnose the reaction or guarantee its course.

4. Do not stop medicines or supplements on your own

Disclose prescriptions, nonprescription medicines, anticoagulant or antiplatelet-related medicines, immune-suppressing medicines, allergies, and supplements. Concern about bleeding or bruising is not a reason to stop or change prescribed treatment without the prescribing clinician.

5. Follow individualized guidance for makeup, exercise, heat, alcohol, and smoking

Resumption depends on product, area, reaction, and combined treatment. Follow the written instruction rather than a universal number of days, and confirm whether and how to use cooling, skincare, and sun protection.

6. Include combined procedures and travel in the recovery plan

Do not assume an order or interval for lasers, energy devices, or other injections. Share long-distance travel, important events, exercise, departure, and access to follow-up; compare delay or alternatives when reassessment would not be available.

7. Recovery record

Item	Record	Response
Product and procedure	Product, lot, area, amount, combined items	Compare consent with actual use
Reaction	Onset, extent, persistence, worsening, photographs	Seek review when it differs from written expectation
Contact	Office hours, after-hours route, emergency threshold	Prioritize local emergency care for urgent symptoms

7. Who Needs Skin Boosters?

Topics to discuss at consultation:

Dehydrated skin: "No matter what I apply, my skin is always dry." "My skin feels tight and flaky."

Loss of elasticity: "My skin started sagging in my mid-30s." "Fine lines keep increasing."

Dull skin tone: "My skin looks tired and dull." "People say I look tired."

Large pores: "My pores are getting bigger." "My skin texture is rough."

Skin regeneration needs: "I have acne scars." "My skin barrier is damaged."

Consultation Needed If You Have:

• Keloid tendency
• Pregnancy or breastfeeding
• Autoimmune conditions
• Active skin infections or inflammation
• HA allergy

---

8. Compared to Other Treatments

Skin Booster vs Botox

Feature	Skin Booster	Botox
Purpose	Hydration, skin quality	Wrinkle reduction (expression lines)
Mechanism	HA injection	Muscle relaxation
Area	Entire face	Specific areas (forehead, glabella)
Duration	varies by product, formulation, area, and plan	Varies by product, area, and individual

Great together! Botox for expression lines + Skin Booster for skin quality = complementary effects.

Skin Booster vs Filler

Feature	Skin Booster	Filler
Purpose	Skin quality improvement	Volume, contouring
Depth	Plane depends on product, goal, and technique	Plane depends on product, goal, and technique
Particle size	Varies by formulation	Varies by formulation
Effect	Natural improvement	Immediate volume

Skin Booster vs Laser Toning

Feature	Skin Booster	Laser Toning
Purpose	Hydration, elasticity	Pigmentation, tone
Method	Injection	Laser
Downtime	Varies by plan and individual response	Varies by device, settings, and skin response
Duration	varies by product, formulation, area, and plan	Varies by device, plan, and individual

Synergy combo! Laser for pigmentation + Skin Booster for hydration and elasticity = perfect!

---

A starting point for understanding skin boosters

Products differ in ingredients and formulation, including hyaluronic acid (HA), polynucleotides (PN), and combinations of PDLLA and HA. Skin aging or hydration changes do not occur at one fixed rate or in one fixed pattern for every person, and findings for one ingredient category cannot be applied directly to another product.

A current overview of injectable skin boosters and a systematic review of PN discuss the possibility of some aesthetic skin improvements, but their study designs and products vary and long-term outcomes remain limited. Evidence overview · PN systematic review

Questions by ingredient category

Category	Example	What to confirm
HA	Injectables intended for hydration	Formulation, treatment area, product-specific evidence
PN	PN-containing products	Exact ingredients, scope of studies, expected reactions
Collagen-stimulating or other categories	Juvelook, Re2O, GOURI, KLOSOME	Product classification, labelled use, product-specific human evidence and its limits

This table does not rank products or determine suitability. Do not predict effects, duration, injection volume, or recovery from a product name alone; review the individual evidence.

Recovery and safety

Injection marks, redness, swelling, bruising, or pain may occur after injection, and their degree and duration vary by person. There is no fixed recovery day or exercise-resumption schedule that applies to everyone. If symptoms worsen or there is severe pain, warmth, spreading redness, or swelling, contact the treating clinic without waiting.

Do not stop or change medications or supplements on your own, including aspirin or omega-3. Tell both the prescribing clinician and the treating clinician about them. Share active infection or inflammation, pregnancy or breastfeeding, allergies, recent procedures, and travel or exercise plans before consultation. Suitability is not determined by season alone; follow individualized guidance based on skin condition and recovery planning.

Consultation checklist

• Confirm the exact product name, ingredient category, and labelled-use information.
• Ask about human studies for that product and their limitations.
• Receive an explanation of the treatment area and plan, expected reactions, and contact criteria.
• Tell the clinician about medications, supplements, and health conditions.
• Decide on repetition and intervals after reviewing previous reactions and individual condition.

9. Frequently Asked Questions (FAQ)

Q1. How painful is a skin-booster procedure?

Pain varies with ingredient and formulation, amount, area, needle, cannula or device, anesthetic method, and individual sensitivity. Numbing cream or lidocaine does not establish a fixed reduction or guarantee a painless procedure. When a separate product such as Rejuran HB plus is mentioned, distinguish it from the original product and check its own IFU, ingredients, and contraindications.

Q2. How many sessions and what interval are needed?

There is no series or interval common to the entire category. Use the actual label, conditions in direct product research, area and goal, first response, adverse reactions, and schedule. Before each repeat, reassess the reason to continue and alternatives instead of selecting a package or fixed course first.

Q3. How long do effects last?

One duration cannot cover products with different ingredient categories, study designs, procedure conditions, and outcome measures. Do not convert a manufacturer statement or study time point into an individual guarantee. Compare the study population, area, series, and follow-up with the proposed plan.

Q4. When can makeup be used?

Follow the actual product document and written guidance for the area, skin condition, and combined procedure rather than a universal number of hours. If the barrier is disrupted or unexpected redness, pain, or discharge is present, do not cover it with makeup before obtaining review.

Q5. When can exercise resume?

It depends on exercise type, heat, sweat, friction, area, and current reaction. Do not apply a fixed day-zero, day-three, or one-week rule; adjust intensity according to the written instruction. Stop and contact the clinic if pain, swelling, or color change worsens with exercise.

Q6. Can it be performed in summer or during strong sun exposure?

Season alone does not determine suitability. Review active skin disease, sun exposure, travel and outdoor plans, combined procedures, and ability to follow sun-protection guidance. Confirm the appropriate sunscreen and restart timing for the actual procedure.

Q7. Can it be combined with another procedure?

Botulinum toxin, lasers and energy devices, fillers, and threads have different goals and risks; combination does not automatically create synergy. Document every product or device, area, order, interval, evidence, and how an unexpected reaction would be attributed before combining.

Conclusion: Choose the Evidence Scope, Not Just the Product Name

A skin booster is not one product or one outcome. Ingredient, formulation, regulatory scope, human evidence, area, and recovery plan differ, so individual goal and acceptable risk should be reviewed before trends or packages.

Final checks before choosing

• Exact product — ingredient, model and amount, lot, and agreement between package and record
• Evidence scope — product-specific human data and limits in sample, area, series, and follow-up
• Individual suitability — inflammation, skin disease, prior procedures, medicines, allergies, important dates
• Alternatives — noninjection care, another category, delay, or observation
• Recovery and contact — expected reactions, written instructions, after-hours or post-travel contact, emergency threshold

Cellinique's stated operating process can be confirmed directly at consultation; this article does not guarantee an outcome or comparative superiority. Individual diagnosis and suitability require the actual product document and clinical assessment.